Entrada Therapeutics, Inc.TRDANASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Price-to-sales ratio

Percentile
P100
Near historical high
vs 2Y Ago
4.3x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
202516.73+446.7%
20243.06-20.8%
20233.87-
20220.00-
20210.00-
20200.00-
20190.00-